Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy

BACKGROUND: People who inject drugs (PWID) constitute 60% of the approximately 5 million people in the U.S. infected with hepatitis C virus (HCV). Treatment of PWID is complex due to addiction, mental illness, poverty, homelessness, lack of positive social support, poor adherence-related skills, low...

Descripción completa

Detalles Bibliográficos
Autores principales: Akiyama, Matthew J., Agyemang, Linda, Arnsten, Julia H., Heo, Moonseong, Norton, Brianna L., Schackman, Bruce R., Linas, Benjamin P., Litwin, Alain H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807730/
https://www.ncbi.nlm.nih.gov/pubmed/29426304
http://dx.doi.org/10.1186/s12879-018-2964-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807730/
https://www.ncbi.nlm.nih.gov/pubmed/29426304
http://dx.doi.org/10.1186/s12879-018-2964-5

Ejemplares similares